节点文献

一种新的血管紧张素I转换酶抑制剂八肽与P物质3-4对人转换酶抑制作用的研究

Biolgical Activity of a New AngiotensinⅠConverting Enzyme Inhibitor and a N-terminal Fragment of Substance P

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 郭春远刘传弟盛树力刘爱民陈雁江胡晓愚

【Author】 Guo Chunyuan, Liu Chuandi XuanWu Hospital, Capital Institute of Medicine Sheng Shuli, Liu Aimin, Chen Yanjiang Beijing Neurosurgical Institute Hu xiaoyu Lanzhou University

【机构】 首都医学院宣武医院首都医学院宣武医院北京市神经外科研究所兰州大学

【摘要】 用固相法合成了一种新的肽类血管紧张素Ⅰ转换酶抑制剂(AI,Pro-Thr-His-Ile-Lys-TrpGly-Asp)和P物质N末端片段(SP3-4,Gly-Phy),并检测了AI和SP3-4对人血浆、脑和肺组织中血管紧张素Ⅰ转换酶(ACE)的抑制作用,结果表明:①合成的AI和SP3-4经HPLC分离鉴定纯度均为>95%,②AI抑制人血浆(IC50 19±4.6/μmol/L)脑(IC50 26±6.3μmol/L)和肺(2例,IC50 119~14.1μmol/L)中ACE活性,SP3-4对人体内ACE活性无抑制。

【Abstract】 A new angiotensin I converting enzyme inhibitor(AI, Pro-Thr-His-Ile-Lys Trp-Gly-Asp) and a N-terminal fragment of substance P (SP3-4, Gly-Phy) were synthesized by solid phase method. Their capacity to inhibit angiotensin I converting enzyme (ACE) seperated from human blood, brain and lung was tested by biochemical assay. Results showed that 1. All of the synthetic peptides were_assayed and their purity was>95% as established by HPLC analysis. 2. The AI inhibited the ACE from human blood(IC50 19±4.6μmol/L) brain (IC50 26±6.3μmol/L) and lung (2 cases, IC5011.9~14.1μmol/L) but the SP3-4 failed to inhibited the ACE from human being.

  • 【文献出处】 首都医学院学报 ,Journal of Capital University of Medical Sciences , 编辑部邮箱 ,1990年04期
  • 【被引频次】1
  • 【下载频次】13
节点文献中: 

本文链接的文献网络图示:

本文的引文网络